Is Big Pharma's Next Target Already in Play?

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

What's Going On With Coinbase Stock Friday?

Dylan Berman
February 14, 2025

Coinbase Global, Inc. (NASDAQ:COIN) shares are trading lower on Friday amid a possible selloff. The stock initially traded higher on Thursday after the company reported 2024 fiscal-year fourth-quarter earnings.

The Details: Coinbase reported earnings per share of $4.68. In addition, the company reported sales of $2.27 billion, beating analysts’ estimate of $1.83 billion.

Coinbase broke down its revenue further. It reported transaction revenue of $1.6 billion, representing a 172% quarter-over-quarter increase. Furthermore, it reported subscription and services revenue of $641 million, up 15% quarter-over-quarter.

The company announced $439 billion in quarterly trading volume and $404 billion in assets on the platform. It reported adjusted EBITDA of $1.3 billion, its highest ever.

“It's the dawn of a new era for crypto. Crypto's voice was heard loud and clear in the US elections, and the era of regulation via enforcement that crippled our industry in the US is on its way out. The Trump Administration is moving fast to fulfill its promise of making the US the crypto capital of the planet, and globally, leaders are taking notice and increasing their attention and investment into crypto,” said Coinbase in a letter to shareholders.

Coinbase issued guidance for the 2025 fiscal year’s first quarter. It sees subscription and services revenue from $685 million to $785 million. The company, as of February 11, has generated about $750 million in transaction revenue.

Analyst Changes: Following the earnings report, multiple analysts issued price target adjustments.

  • JMP Securities analyst Devin Ryan maintained a Market Outperform rating and raised the price target from $400 to $475.
  • Canaccord Genuity analyst Joseph Vafi maintained a Buy rating and raised the price target from $280 to $400.
  • Piper Sandler analyst Patrick Moley maintained a Neutral rating and raised the price target from $285 to $310.

Related Link: Pfizer’s Talzenna/Xtandi Combo Improves Survival Outcomes In Metastatic Castration-Resistant Prostate Cancer

COIN Price Action: At the time of writing, Coinbase stock is trading 6.56% lower at $278.61, according to data from Benzinga Pro.

Image: via Shutterstock

Continue Reading...

Popular

New York advances casinos at a Bronx golf course and near Mets stadium

NEW YORK (AP) — Casinos proposed for a golf course in the Bronx and next to the New York Mets’ ballpark are poised to cash in on a for the New York City area.

A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad

Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.

Trump Threatens Air Traffic Controllers Amid Shutdown Chaos; Pete Buttigieg Says He 'Wouldn't Last Five Minutes' in Their Job

President Donald Trump has demanded that all air traffic controllers return to work as the nation's aviation system endured another wave of mass flight cancellations, caused by staffing shortages due to the prolonged government shutdown.

Velo3D Stock Soars After Q3 Earnings: Highlights From The Report

Shares of Velo3D, Inc. (NASDAQ:VELO) are rising Tuesday after the metal 3D printing company reported third-quarter earnings results.

Urgent Copper Stock With Strong Catalysts - Ad

Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.

Marjorie Taylor Greene Buys Blue Chip Stock Near 52-Week Low

Marjorie Taylor Greene is known for buying multiple stocks at a time, based on recent disclosures. A new filing shows one stock bought in November.

Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad

AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.

Scaramucci Says This One US Mistake Helped China Become a Manufacturing Superpower

Anthony Scaramucci recently highlighted what he considers a significant error by the US that enabled China to ascend as a manufacturing superpower.

Asian shares are mostly lower despite Wall St rally and a potential end to the US shutdown

BANGKOK (AP) — Asian shares were mostly lower on Tuesday as the recent rebound fueled by buying of technology shares lost steam.

Copper, Silver, Gold, Tungsten - This Nevada Play Offers Multiple Shots on Goal - Ad

Most early-stage resource opportunities rely on one metal. This one doesn't. The Walker Lane belt hosts copper, silver, gold, and tungsten - and recent results across the district confirm all four. This startup has stepped in with multi-metal exposure, giving investors several potential ways to capture upside.

Cathie Wood Dumps $11.6 Million Worth Of Tesla Stock: Here Is What Ark Purchased Instead

On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Tesla Inc. (NASDAQ:TSLA), Coinbase Global Inc.

Weiss Gold Veteran Makes Shocking New Call - Ad

Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.

How Tyson's Chicken Business Will Offset Beef Weakness

Tyson shares rise as pricing catch-up expected to ease cost pressures; chicken strength offsets beef headwinds amid stable feed costs.

Donald Trump Nullifies 92% Of Joe Biden's Autopen-Signed Documents: 'Cancelling All Executive Orders And Anything Else'

Trump moved to invalidate what he claims are most of Biden's autopen-signed actions, sparking political backlash and renewed debate over the legality and precedent of using mechanical signatures for presidential documents.

First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad

This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.

A lost generation of news consumers? Survey shows how teenagers dislike the news media

NEW YORK (AP) — Cat Murphy, a college student, has wanted to be a journalist since she was 11. Many of her friends don't understand why.

These are the 37 donors helping pay for Trump's $300 million White House ballroom

WASHINGTON (AP) — President Donald Trump says his $300 million White House ballroom will be paid for “100% by me and some friends of mine.”

Trump Just Signed s.1582 Into Law - Now the Countdown Begins... - Ad

A quiet shift in U.S. law has just authorized private companies to mint a new form of government-authorized money called the "Dollar 2.0"... and the next major mint hits on December 18. Investors who make the right moves before then could make up to 40X by 2032...

What's Going On With Papa John's (PZZA) Stock Today? (UPDATED)

Shares of Papa John's International, Inc. (NASDAQ: PZZA) moved higher on Monday. Here's what you need to know.

Elon Musk Says Tesla, xAI Are 'Trending Towards Convergence' In Some Ways

Elon Musk's companies could potentially merge in the future as he continues to integrate AI into his ventures.

The Smart Money Copper Trade - Ad

Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.

Analyst Sees Strong Medtronic Momentum Through 2026 With Buy Rating Intact

BofA expects Medtronic to post over 5% second-quarter revenue growth and maintain strong momentum through 2026, driven by robust procedure trends.

Donald Trump Administration's Unprecedented Investment In Private Firms Raises Eyebrows

President Trump administration has invested over $10 billion of taxpayer funds in private companies deemed crucial to national security.

$270,000 Drug. One Competitor. Billion-Dollar Market. - Ad

Phase 3 trial targets recurrent pericarditis with an oral therapy that could disrupt the only approved treatment. And their heart failure program launches in 2026.

Tax-Free Student Loan Forgiveness Expires In 2026, Who Owes More Next Year?

The American Rescue Plan Act of 2021 will make most student loan forgiveness tax-free until 2025, then borrowers may owe thousands in taxes.

Watchdog group Public Citizen demands OpenAI withdraw AI video app Sora over deepfake dangers

The tech industry is moving fast and breaking things again — and this time it is humanity’s shared reality and control of our likeness before and after death — thanks to artificial intelligence image-generation platforms .

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

Serbian protesters vow to prevent real estate project linked to Trump son-in-law Kushner

BELGRADE, Serbia (AP) — Thousands of protesters in Serbia symbolically formed a human shield Tuesday around a bombed-out military complex, vowing to protect it from redevelopment as a luxury compound by a company linked to U.S. President Donald Trump’s son-in-law .

Elon Musk Says SpaceX Will Carry '99% Of All Earth Payload' Once Starship Flies Daily

Elon Musk says SpaceX will handle nearly all of Earth's orbital payloads in the coming years as Starship development continues.

A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad

Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.

Gen Z Takes To 'Income Stacking' As One Pay Check Falls Short

Gen Zers are turning to income stacking to secure their financial future as they fear a single paycheck won't be enough. AI and broken social contract fuel the shift. Side hustles becoming core of young careers.

Auto Industry Faces 'EV Winter' Amid Policy Shifts and Supply Chain Woes

The US auto industry is currently facing a myriad of obstacles that are posing a threat to the expansion of EVs.

Urgent Copper Stock With Strong Catalysts - Ad

Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.

US Senate Discloses Landmark Crypto Market Structure Bill, Eyes Passage By Late 2025

Bitcoin (CRYPTO: BTC) is holding steady near $105,000 as markets digest the Senate's long-awaited crypto market structure bill draft, a major milestone toward regulatory clarity

Why Is Occidental Petroleum Stock Gaining Tuesday?

Analysts highlight OXY's robust earnings, production guidance, and expanded resource base as key growth drivers.

Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad

AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.

Piper Sandler Set For Best-In-Class Growth As Banking Cycles Turn: Analyst

Piper Sandler (PIPR) upgraded to Buy by Goldman Sachs with a target price of $386, projecting an 18% upside.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service